SENSEX NIFTY

Dr Reddys Laboratories

Jan 21, 2017 at 10:26 | Source: Moneycontrol.com
Indian ADRs ended mostly lower on Friday. ICICI Bank was down 0.11 percent and Tata Motors slipped 0.34 percent.
Jan 20, 2017 at 07:57 | Source: Moneycontrol.com
Indian ADRs ended lower on Thursday. ICICI Bank fell 0.16 percent and Infosys was down 0.05 percent.
Jan 19, 2017 at 09:15 | Source: Moneycontrol.com
BHEL, Tata Motors, Dr Reddy's, Adani Ports and Asian Paints are gainers while Axis Bank, GAIL, HUL, ITC, Sun Pharma, TCS are losers in the Sensex.
Jan 19, 2017 at 08:04 | Source: Moneycontrol.com
Indian ADRs ended mixed on Wednesday. ICICI Bank gained 0.15 percent and Tata Motors added 0.14 percent.
Jan 18, 2017 at 13:32 | Source: CNBC-TV18
According to Sandeep Wagle of powermywealth.com, one can buy Tata Elxsi and Vedanta and sell Dr Reddy's Laboratories.
Jan 18, 2017 at 11:00 | Source: Moneycontrol.com
BHEL, HUL, Tata Steel, Adani Ports and L&T are top gainers while Bharti Airtel, NTPC, Dr Reddy's Labs, Bajaj Auto and GAIL are losers in the Sensex.
Jan 18, 2017 at 07:59 | Source: Moneycontrol.com
Indian ADRs ended mostly higher on Tuesday. Tata Motors advanced 0.17 percent and HDFC Bank gained 0.77 percent.
Jan 17, 2017 at 15:37 | Source: Moneycontrol.com
Net Sales are expected to increase by 4.6 percent Q-o-Q (down 5.4 percent Y-o-Y) to Rs 3750 crore, according to HDFC Securities.
Jan 16, 2017 at 12:05 | Source: Moneycontrol.com
Net Sales are expected to increase by 7.4 percent Q-o-Q (down 2.9 percent Y-o-Y) to Rs 3851.4 crore, according to ICICI Securities.
Jan 16, 2017 at 09:34 | Source: CNBC-TV18
Mitessh Thakkar of miteshthacker.com is of the view that one may buy HT Media and Cummins India and advises selling Century Textiles and Dr Reddy's Laboratories.
Messages on Dr Reddys Laboratories »

Wire News

Platinum Member

694 Followers

News Now  

US Food and Drug Administration (USFDA) will re-audit three manufacturing facilities of Dr Reddy's Laboratories in the current quarter.

3.34 PM Jan 12th

BSE/NSE Announcer

Platinum Member

20354 Followers

Dr Reddys Labs  

The Exchange has sought clarification from Dr. Reddys Laboratories Limited with respect to recent news item captioned "FDA to re-audit three Dr.Reddys Labs plants". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including

12.18 PM Jan 12th

BSE/NSE Announcer

Platinum Member

20354 Followers

Dr Reddys Labs  

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated January 09, 2017 titled "Dr. Reddys Laboratories Limited to present at the J.P. Morgan 35th Annual Healthcare Conference".

6.27 PM Jan 9th

BSE/NSE Announcer

Platinum Member

20354 Followers

Dr Reddys Labs  

Dr. Reddys Laboratories Limited has informed the Exchange regarding allotment of 6105 Equity Shares under ESOP

12.24 PM Jan 6th

Wire News

Platinum Member

694 Followers

News Now  

Dr Reddy's Laboratories Ltd today announced the launch of anti-fungal ointment nystatin and triamcinolone acetonide in the US market.

11.52 AM Dec 5th 2016

BSE/NSE Announcer

Platinum Member

20354 Followers

Dr Reddys Labs  

Dr. Reddys Laboratories Limited has informed the Exchange regarding allotment of 15850 Equity Shares under ESOP

11.48 AM Dec 5th 2016

BSE/NSE Announcer

Platinum Member

20354 Followers

Dr Reddys Labs  

Dr Reddy's Laboratories has launched Nystatin and Triamcinolone Acetonide Cream, USP in the US market, approved by USFDA.

11.14 AM Dec 5th 2016

BSE/NSE Announcer

Platinum Member

20354 Followers

Dr Reddys Labs  

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated December 05, 2016, titled "Dr. Reddys Laboratories announces the launch of Nystatin and Triamcinolone Acetonide Cream, USP in the U.S. Market".

11.14 AM Dec 5th 2016

BSE/NSE Announcer

Platinum Member

20354 Followers

Dr Reddys Labs  

Dr. Reddys Laboratories Limited has informed the Exchange regarding a press release dated December 05, 2016, titled "Dr. Reddys Laboratories announces the launch ofNystatin and Triamcinolone Acetonide Cream, USP in the U.S. Market".

11.13 AM Dec 5th 2016

Forum Messenger

Platinum Member

376532 Followers

Dr Reddys Labs  

Is Dr Reddys Laboratories looking good for medium term?

1.32 PM Nov 29th 2016

News across the web »
Oct 10, 2016 at 18:47 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.